Advisor Net Financial, Inc Corcept Therapeutics Inc Transaction History

Advisor Net Financial, Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 19, 2024	SELL	$24.82 - $32.88 $49 - $65	-2 Reduced 8.0%	23 $0
Q3 2023 Oct 12, 2023	BUY	$21.97 - $33.8 $87 - $135	4 Added 19.05%	25 $0
Q2 2023 Jul 14, 2023	SELL	$21.44 - $25.15 $21 - $25	-1 Reduced 4.55%	21 $0
Q1 2023 Apr 28, 2023	BUY	$19.2 - $24.47 $422 - $538	22 New	22 $0
Q3 2020 Nov 06, 2020	SELL	$12.46 - $19.98 $1,246 - $1,998	-100 Closed	0 $0
Q2 2020 Aug 26, 2020	BUY	$11.0 - $18.26 $1,100 - $1,826	100 New	100 $2,000

357

86.3M

1.12M

667K

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $7.13B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of Advisor Net Financial, Inc, based on Form 13F filings with the SEC.

Stay updated on Advisor Net Financial, Inc with notifications on news.